Childhood Lymphoma — Trials

Childhood Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

98 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02624388	Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)(UVA-Gen001)	terminated	Phase 2	4	University of VirginiaOTHER	1	May 6, 2024	clinicaltrials
NCT00354107	Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma	terminated	Phase 1 / Phase 2	5	National Cancer Institute (NCI)NIH	1	Mar 14, 2018	clinicaltrials